Liquidia Corp
NASDAQ:LQDA

Watchlist Manager
Liquidia Corp Logo
Liquidia Corp
NASDAQ:LQDA
Watchlist
Price: 10.51 USD 2.34%
Market Cap: 882.8m USD
Have any thoughts about
Liquidia Corp?
Write Note

Intrinsic Value

The intrinsic value of one LQDA stock under the Base Case scenario is 5.9 USD. Compared to the current market price of 10.51 USD, Liquidia Corp is Overvalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LQDA Intrinsic Value
5.9 USD
Overvaluation 44%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Liquidia Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for LQDA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about LQDA?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Pharmaceuticals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Liquidia Corp

Provide an overview of the primary business activities
of Liquidia Corp.

What unique competitive advantages
does Liquidia Corp hold over its rivals?

What risks and challenges
does Liquidia Corp face in the near future?

Summarize the latest earnings call
of Liquidia Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Liquidia Corp.

Provide P/S
for Liquidia Corp.

Provide P/E
for Liquidia Corp.

Provide P/OCF
for Liquidia Corp.

Provide P/FCFE
for Liquidia Corp.

Provide P/B
for Liquidia Corp.

Provide EV/S
for Liquidia Corp.

Provide EV/GP
for Liquidia Corp.

Provide EV/EBITDA
for Liquidia Corp.

Provide EV/EBIT
for Liquidia Corp.

Provide EV/OCF
for Liquidia Corp.

Provide EV/FCFF
for Liquidia Corp.

Provide EV/IC
for Liquidia Corp.

Show me price targets
for Liquidia Corp made by professional analysts.

What are the Revenue projections
for Liquidia Corp?

How accurate were the past Revenue estimates
for Liquidia Corp?

What are the Net Income projections
for Liquidia Corp?

How accurate were the past Net Income estimates
for Liquidia Corp?

What are the EPS projections
for Liquidia Corp?

How accurate were the past EPS estimates
for Liquidia Corp?

What are the EBIT projections
for Liquidia Corp?

How accurate were the past EBIT estimates
for Liquidia Corp?

Compare the revenue forecasts
for Liquidia Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Liquidia Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Liquidia Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Liquidia Corp compared to its peers.

Compare the P/E ratios
of Liquidia Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Liquidia Corp with its peers.

Analyze the financial leverage
of Liquidia Corp compared to its main competitors.

Show all profitability ratios
for Liquidia Corp.

Provide ROE
for Liquidia Corp.

Provide ROA
for Liquidia Corp.

Provide ROIC
for Liquidia Corp.

Provide ROCE
for Liquidia Corp.

Provide Gross Margin
for Liquidia Corp.

Provide Operating Margin
for Liquidia Corp.

Provide Net Margin
for Liquidia Corp.

Provide FCF Margin
for Liquidia Corp.

Show all solvency ratios
for Liquidia Corp.

Provide D/E Ratio
for Liquidia Corp.

Provide D/A Ratio
for Liquidia Corp.

Provide Interest Coverage Ratio
for Liquidia Corp.

Provide Altman Z-Score Ratio
for Liquidia Corp.

Provide Quick Ratio
for Liquidia Corp.

Provide Current Ratio
for Liquidia Corp.

Provide Cash Ratio
for Liquidia Corp.

What is the historical Revenue growth
over the last 5 years for Liquidia Corp?

What is the historical Net Income growth
over the last 5 years for Liquidia Corp?

What is the current Free Cash Flow
of Liquidia Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Liquidia Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Liquidia Corp

Current Assets 147.3m
Cash & Short-Term Investments 133.1m
Receivables 3.2m
Other Current Assets 10.9m
Non-Current Assets 30.1m
PP&E 7.9m
Intangibles 7.2m
Other Non-Current Assets 15m
Current Liabilities 24.2m
Accounts Payable 5.7m
Accrued Liabilities 14.3m
Other Current Liabilities 4.2m
Non-Current Liabilities 90.4m
Long-Term Debt 81.8m
Other Non-Current Liabilities 8.7m
Efficiency

Earnings Waterfall
Liquidia Corp

Revenue
14.8m USD
Cost of Revenue
-4.5m USD
Gross Profit
10.3m USD
Operating Expenses
-107.6m USD
Operating Income
-97.3m USD
Other Expenses
-14.8m USD
Net Income
-112.1m USD

Free Cash Flow Analysis
Liquidia Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

LQDA Profitability Score
Profitability Due Diligence

Liquidia Corp's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
Negative 1-Year Revenue Growth
25/100
Profitability
Score

Liquidia Corp's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

LQDA Solvency Score
Solvency Due Diligence

Liquidia Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
50/100
Solvency
Score

Liquidia Corp's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LQDA Price Targets Summary
Liquidia Corp

Wall Street analysts forecast LQDA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LQDA is 25.84 USD with a low forecast of 17.17 USD and a high forecast of 31.5 USD.

Lowest
Price Target
17.17 USD
63% Upside
Average
Price Target
25.84 USD
146% Upside
Highest
Price Target
31.5 USD
200% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LQDA?

Click here to dive deeper.

Dividends

Liquidia Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for LQDA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Liquidia Corp Logo
Liquidia Corp

Country

United States of America

Industry

Pharmaceuticals

Market Cap

803.1m USD

Dividend Yield

0%

Description

Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. The company is headquartered in Morrisville, North Carolina and currently employs 47 full-time employees. The company went IPO on 2018-07-26. PRINT technology is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. The firm is engaged in developing product candidates from its pipeline, LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. LIQ861 is an inhaled dry powder formulation of treprostinil designed to improve the therapeutic profile of treprostinil by enhancing deep-lung delivery and achieving higher dose levels than current inhaled therapies. LIQ865, has completed a Phase Ib clinical trial, is designed to deliver sustained-release particles of bupivacaine, a non-opioid anesthetic and to treat local post-operative pain.

Contact

NORTH CAROLINA
Morrisville
419 Davis Drive, Suite 100, Suite
+19193284400.0
www.liquidia.com

IPO

2018-07-26

Employees

47

Officers

CEO & Director
Dr. Roger A. Jeffs Ph.D.
COO & CFO
Mr. Michael Kaseta
General Counsel & Corporate Secretary
Mr. Russell Schundler
Co-Founder
Dr. Ginger Denison
Vice President of People & Culture
Ms. Sarah Krepp SPHR
Chief Business Officer
Mr. Jason Adair
Show More
Chief Commercial Officer
Mr. Scott Moomaw
Chief Medical Officer
Dr. Rajeev Saggar M.D.
Senior Vice President of Manufacturing Operations
Mr. Michael Hunter
Show Less

See Also

Discover More
What is the Intrinsic Value of one LQDA stock?

The intrinsic value of one LQDA stock under the Base Case scenario is 5.9 USD.

Is LQDA stock undervalued or overvalued?

Compared to the current market price of 10.51 USD, Liquidia Corp is Overvalued by 44%.

Back to Top